Bovine Tuberculosis
Could modernising a century-old calliper transform bovine TB testing? Collaboration reveals how precision tools, digital data and smarter design could reshape accuracy, consistency and future surveillance success.
On World TB Day, APHA highlights progress in Phase 3 cattle TB vaccine trials, underscoring ongoing efforts to tackle bovine tuberculosis.
Read about our Cattle Vaccine Project: APHA’s invaluable addition to the toolbox to eradicate bovine TB in the UK.
This World TB Day, APHA disease scientist Siân Powell describes a long-standing project at Woodchester Park to better understand TB disease spread in badger populations and advancements in our diagnostic capabilities.
APHA is building increasingly more sophisticated tools to integrate full genome sequences with epidemiological information enabling visualisation of how disease is spreading. In this two-minute read, learn about how APHA is using this technology in practice.
Bovine Tuberculosis (bTB) is an infectious disease of cattle. It is one of the most significant animal health challenges that England faces today, costing taxpayers more than £100 million each year. In 2020 alone, more than 27,000 cattle had to be slaughtered to curb its spread.
In this science blog we look at what bovine tuberculosis is (bTB) and why we need to eradicate it.
In the first of a series of blogs, read about our Cattle Vaccine Project: APHA’s invaluable addition to the toolbox to eradicate bovine TB in the UK.
Stefan Berg, senior scientist at APHA, highlights the agency’s 15-years engagement in collaborative research on bovine tuberculosis (bTB) in Ethiopia.
Epidemiologists at APHA have teamed up with researchers at Oxford University to try and identify what risk factors drive the spread of bovine TB in different areas.
Recent Comments